Opendata, web and dolomites

ViaOne

A MINIMALLY INVASIVE NEEDLE FREE DEVICE TO SAFELY ACCESS THE PERICARDIUM SPACE

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ViaOne project word cloud

Explore the words cloud of the ViaOne project. It provides you a very rough idea of what is the project "ViaOne" about.

130    tools    market    epicardial    representing    secure    bleeding    penetration    device    needle    expertise    24m    commercial    acute    workspace    pericardial    healthcare    tamponade    geometrically    atrial    opportunity    medical    fact    disorders    business    outcomes    marketable    5m    competitive    fibrillation    cardiac    successful    constant       additional    price    mapping    pathologies    ablations    2021    invasive    sme    cardiovascular    employs    electrohpysiological    puncture    050670    250    structured    complications    af    deaths    manner    area    needles    clinical    catheters    big    skill    il2018    variety    pathological    arrhythmia    avoiding    equivalent    patient    free    heart    motion    treatment    people    thread    safe    ensures    performed    pct    first    release    30    confident    requiring    commercialize    ablation    surgery    procedure    space    11m    financial    2016    600m    patients    epiviasystem    pericardium    optimize    techniques    feasibility    reduce    failed   

Project "ViaOne" data sheet

The following table provides information about the project.

Coordinator
CARDIOVIA LTD. 

Organization address
address: WADI EL HAJ 13
city: NAZARETH
postcode: 1600101
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.cardiovia.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARDIOVIA LTD. IL (NAZARETH) coordinator 50˙000.00

Map

 Project objective

2.5M patients per year in the US and the EU require pericardial space access as the result of a variety of pathological conditions. Atrial Fibrillation (AF) is the most common condition requiring pericardial access, in fact, AF affected 24M people in the US and 11M in the EU (2016). In current epicardial access techniques (using needles), complications can reach 4.5-30% (representing a Ëž€600M/year increase in costs for healthcare systems) and includes heart puncture, cardiac tamponade and pericardial bleeding, which can result in an increase in patient deaths. The use of a needle in the heart area, which is in constant motion, requires a high level of skill and expertise during surgery. EpiVIASYSTEM is the first device (PCT /IL2018 /050670) to ensure pericardial access in a confident, safe, needle-free manner avoiding complications during penetration of the pericardium. The device employs a unique geometrically structured thread that ensures a secure workspace for the use of additional cardiovascular devices, such as mapping and ablation catheters for treatment of arrhythmia disorders. Its design will ensure a competitive price of €250/procedure when compared with €130 for the equivalent tools used in invasive non-electrohpysiological procedures. EpiVIASYSTEM is expected to improve clinical outcomes of patients and reduce costs associated with failed ablations associated with the needle use by €600M/year. The increased growth of cardiac pathologies and the 2.5M of patients/year that require pericardial access represent a big business opportunity for the EpiVIASYSTEM and will favour its successful market uptake. EpiVIASYSTEM´s main objective is to optimize, scale-up and commercialize a marketable medical device in both the EU and the US by 2021. For that, a feasibility study will be performed during SME Phase 1 to evaluate any technical, commercial and/or financial issues and ensure the successful release of the EpiVIASYSTEM into the market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VIAONE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VIAONE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

PAROST (2019)

Disruptive technology for the identification, quantification and prediction of the evolution of damages in civil engineering structures that increases safety while reducing maintenance costs.

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More